Aureus Greenway Holdings And 2 Other Promising Penny Stocks To Watch

As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average climbing 515 points and the S&P 500 nearing a record high. In this context of market optimism, investors are increasingly looking at diverse opportunities across different sectors. Though 'penny stocks' might seem like an outdated term, they still signify smaller or newer companies that can offer substantial growth potential when backed by strong financials. By focusing on these types of stocks with solid fundamentals and growth prospects, investors may uncover hidden gems in the market capable of delivering impressive returns.

Top 10 Penny Stocks In The United States

Name Share Price Market Cap Financial Health Rating Dingdong (Cayman) (DDL) $2.83 $619.34M ★★★★★★ Waterdrop (WDH) $1.79 $640.14M ★★★★★☆ LexinFintech Holdings (LX) $3.00 $464.41M ★★★★★★ Global Self Storage (SELF) $4.98 $56.58M ★★★★★☆ Information Services Group (III) $3.11 $226.97M ★★★★★★ Golden Growers Cooperative (GGRO.U) $5.00 $77.45M ★★★★★★ Cricut (CRCT) $4.58 $993.08M ★★★★★★ Nephros (NEPH) $4.00 $43.57M ★★★★★★ LifeVantage (LFVN) $4.94 $64.35M ★★★★★★ Lifetime Brands (LCUT) $3.29 $77.48M ★★★★★☆

Click here to see the full list of 345 stocks from our US Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Aureus Greenway Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Aureus Greenway Holdings Inc. operates public golf country clubs in Florida through its subsidiaries and has a market cap of $59.92 million.

Operations: The company generates $2.93 million in revenue from its recreational activities segment.

Market Cap: $59.92M

Aureus Greenway Holdings Inc., with a market cap of US$59.92 million, operates public golf country clubs in Florida but faces challenges typical of penny stocks, such as high share price volatility and unprofitability. Despite generating US$2.93 million in revenue from its recreational activities segment, the company remains unprofitable with a negative return on equity of -8.25%. Recent executive changes include the appointment of Matthew J. Saker as interim CEO and Christopher Schraft as an independent director, both bringing extensive experience to potentially guide strategic transformations amidst ongoing financial hurdles and limited meaningful revenue growth.

Navigate through the intricacies of Aureus Greenway Holdings with our comprehensive balance sheet health report here. Assess Aureus Greenway Holdings' previous results with our detailed historical performance reports.AGH Debt to Equity History and Analysis as at Feb 2026

DocGo

Simply Wall St Financial Health Rating: ★★★★★☆

Story Continues

Overview: DocGo Inc. operates by offering mobile health and medical transportation services in the United States and the United Kingdom, with a market cap of $72.91 million.

Operations: DocGo's revenue is derived from its Mobile Health Services, generating $168.46 million, and Transportation Services, contributing $199.64 million.

Market Cap: $72.91M

DocGo Inc., with a market cap of US$72.91 million, faces challenges typical of penny stocks, including recent non-compliance with Nasdaq's minimum bid requirement, risking potential delisting unless resolved by July 2026. Despite unprofitability and increasing losses over the past five years, DocGo has strong liquidity with short-term assets exceeding liabilities and cash surpassing total debt. The company is expanding its virtual care division to meet growing demand for telehealth services but remains under scrutiny due to ongoing legal settlements and management changes. Its stock trades significantly below estimated fair value, reflecting market skepticism amidst operational uncertainties.

Unlock comprehensive insights into our analysis of DocGo stock in this financial health report. Understand DocGo's earnings outlook by examining our growth report.DCGO Revenue & Expenses Breakdown as at Feb 2026

Next Steps

Jump into our full catalog of 345 US Penny Stocks here. Ready For A Different Approach? AI is about to change healthcare. These 105 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AGH and DCGO.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments